CA2981705A1 - Antimicrobial peptides and methods of use thereof - Google Patents

Antimicrobial peptides and methods of use thereof Download PDF

Info

Publication number
CA2981705A1
CA2981705A1 CA2981705A CA2981705A CA2981705A1 CA 2981705 A1 CA2981705 A1 CA 2981705A1 CA 2981705 A CA2981705 A CA 2981705A CA 2981705 A CA2981705 A CA 2981705A CA 2981705 A1 CA2981705 A1 CA 2981705A1
Authority
CA
Canada
Prior art keywords
antimicrobial
amino acid
composition
seq
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2981705A
Other languages
English (en)
French (fr)
Inventor
Jesse Jaynes
Edward Clemens L.
Henry W. Lopez
George R. Martin
Kathryn Woodburn
Original Assignee
Riptide Bioscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riptide Bioscience Inc filed Critical Riptide Bioscience Inc
Publication of CA2981705A1 publication Critical patent/CA2981705A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
CA2981705A 2015-03-23 2016-03-23 Antimicrobial peptides and methods of use thereof Abandoned CA2981705A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562137206P 2015-03-23 2015-03-23
US62/137,206 2015-03-23
PCT/US2016/023801 WO2016154328A2 (en) 2015-03-23 2016-03-23 Antimicrobial peptides and methods of use thereof

Publications (1)

Publication Number Publication Date
CA2981705A1 true CA2981705A1 (en) 2016-09-29

Family

ID=56978879

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2981705A Abandoned CA2981705A1 (en) 2015-03-23 2016-03-23 Antimicrobial peptides and methods of use thereof

Country Status (8)

Country Link
US (2) US10017542B2 (https=)
EP (2) EP3903823A3 (https=)
JP (2) JP6964577B2 (https=)
KR (1) KR20180002618A (https=)
CN (2) CN107614004B (https=)
AU (2) AU2016235147B2 (https=)
CA (1) CA2981705A1 (https=)
WO (1) WO2016154328A2 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10017542B2 (en) * 2015-03-23 2018-07-10 Riptide Bioscience, Inc. Antimicrobial peptides and methods of use thereof
US20200131231A1 (en) 2017-02-17 2020-04-30 Oxford University Innovation Limited Cell penetrating peptides
GB201812972D0 (en) 2018-08-09 2018-09-26 Univ Oxford Innovation Ltd Cell-penetrating peptides
GB201812980D0 (en) 2018-08-09 2018-09-26 Univ Oxford Innovation Ltd Cell-penetrating peptides
CA3110618A1 (en) * 2018-08-29 2020-03-05 Riptide Bioscience, Inc. Peptides having immunomodulatory properties
US10413584B1 (en) 2018-08-29 2019-09-17 Riptide Bioscience, Inc. Peptides having immunomodulatory properties
US20200102356A1 (en) * 2018-10-01 2020-04-02 NMC Inc. Compositions and Methods for the Treatment of Huanglongbing (HLB) aka Citrus Greening in Citrus Plants
JP7755994B2 (ja) * 2018-10-19 2025-10-17 リップタイド バイオサイエンス インコーポレイテッド 抗菌性ペプチド及びその使用方法
US10548944B1 (en) * 2018-10-19 2020-02-04 Riptide Bioscience, Inc. Antimicrobial peptides and methods of using the same
US12465646B2 (en) 2018-12-07 2025-11-11 Oxford University Innovation Limited Linkers
US12509414B2 (en) * 2019-04-04 2025-12-30 National Taiwan Ocean University Carbon quantum dot, a composition thereof and a method for treating infection by using same
KR20210151945A (ko) 2019-04-12 2021-12-14 립타이드 바이오사이언스, 인코포레이티드 대식세포 활성을 조정하기 위한 방법
CN110305193B (zh) * 2019-07-18 2021-10-08 河南科技大学 一种抗牙龈卟啉单胞菌多肽及应用
AU2021246017A1 (en) * 2020-03-31 2022-11-10 Innate Immunity LLC Recombinant peptide to treat fire blight
US20240287135A1 (en) * 2021-09-03 2024-08-29 Qc Bio-Technology (Shenzhen) Co., Ltd. Antimicrobial peptide or peptide derivative, substitute, and composition thereof, and preparation method and application of composition
CN114989254B (zh) * 2022-06-17 2023-11-03 中山大学 一种多肽及其设计方法和在制备抑制具核梭杆菌产品或预防结直肠癌药物中的应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL90356A0 (en) * 1988-05-27 1989-12-15 Magainin Sciences Inc Amphiphilic peptides and pharmaceutical compositions containing them
CA2032527C (en) * 1989-04-10 2002-07-02 Jesse M. Jaynes Lytic peptides: their use in the treatment of microbial infections, cancer and in the promotion of growth
US5561107A (en) * 1993-06-04 1996-10-01 Demeter Biotechnologies, Ltd. Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
IL114697A0 (en) * 1994-07-22 1995-11-27 Demeter Biotech Ltd Polypeptides comprising ubiquitin-lytic peptide fusion protein products deriving therefrom their preparation and use
JPH08134075A (ja) * 1994-11-02 1996-05-28 Yamanouchi Pharmaceut Co Ltd 新規なカルバペネム誘導体
CA2242660A1 (en) * 1996-02-16 1997-08-21 The Regents Of The University Of California Antimicrobial peptides and methods of use
JP2001501620A (ja) * 1996-10-04 2001-02-06 デメジェン インコーポレイテッド 免疫不全ウイルス感染の治療方法
US6680058B1 (en) * 1997-09-03 2004-01-20 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Compositions and methods for contraception in or sterilization of mammals
IL146743A0 (en) * 1999-05-31 2002-07-25 Novozymes As Screening method for peptides
US6432415B1 (en) * 1999-12-17 2002-08-13 Axrix Laboratories, Inc. Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces
AU2003269851A1 (en) * 2002-10-09 2004-05-04 Novozymes A/S A method for screening for an antimicrobial polypeptide
KR101413746B1 (ko) * 2005-12-22 2014-07-01 노바바이오틱스 리미티드 고리형 항균 펩타이드
NZ571989A (en) * 2006-03-23 2012-07-27 Agriculture Victoria Serv Pty Antimicrobial protein
CN101448851B (zh) * 2006-05-16 2013-11-06 佩加马公司 改进的抗微生物肽
US7288622B1 (en) * 2006-09-19 2007-10-30 Issar Pharmaceuticals Pvt Ltd Composition for treatment of burns and wounds
US7803755B2 (en) * 2006-12-21 2010-09-28 Jesse Jaynes Molecules for the treatment and prevention of fungal diseases
US9163066B2 (en) * 2010-06-29 2015-10-20 Agromed Llc Antimicrobial lytic peptides
EP2468856A1 (en) * 2010-12-23 2012-06-27 Lysando Aktiengesellschaft Antimicrobial Agents
US10017542B2 (en) * 2015-03-23 2018-07-10 Riptide Bioscience, Inc. Antimicrobial peptides and methods of use thereof

Also Published As

Publication number Publication date
CN115475232A (zh) 2022-12-16
US20160296594A1 (en) 2016-10-13
EP3903823A2 (en) 2021-11-03
US20190071470A1 (en) 2019-03-07
JP2021054842A (ja) 2021-04-08
JP6964577B2 (ja) 2021-11-10
KR20180002618A (ko) 2018-01-08
AU2019222918A1 (en) 2019-09-19
JP2018512454A (ja) 2018-05-17
US10017542B2 (en) 2018-07-10
CN107614004A (zh) 2018-01-19
EP3903823A3 (en) 2022-02-23
AU2016235147B2 (en) 2019-09-19
EP3274472A2 (en) 2018-01-31
WO2016154328A2 (en) 2016-09-29
EP3274472A4 (en) 2018-12-05
AU2016235147A1 (en) 2017-10-26
AU2019222918B2 (en) 2021-10-21
EP3274472B1 (en) 2020-09-23
JP7267251B2 (ja) 2023-05-01
CN107614004B (zh) 2022-12-06

Similar Documents

Publication Publication Date Title
AU2019222918B2 (en) Antimicrobial peptides and methods of use thereof
Boparai et al. Mini review on antimicrobial peptides, sources, mechanism and recent applications
Mirski et al. Utilisation of peptides against microbial infections–a review
US12115209B2 (en) ROMO1-derived antimicrobial peptides including lysine substitution and variants thereof
WO2014182172A1 (en) Antimicrobial peptide
Simonetti et al. In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria
US11266712B2 (en) Antimicrobial peptides and methods of using the same
KR101953828B1 (ko) 왕귀뚜라미에서 유래한 항균 펩타이드 테레오그릴루신 1 및 그의 조성물
KR101953834B1 (ko) 왕귀뚜라미에서 유래한 항균 펩타이드 테레오그릴루신 2 및 그의 조성물
EP3298025B1 (en) New amino acid sequences with microbicidal activity derived from naja atra cardiotoxin 1 (ctx-1)
KR101889404B1 (ko) 바퀴벌레에서 유래한 항균 펩타이드 페리플라네타신-5 및 그의 조성물
EP3866826B1 (en) Antimicrobial peptides and methods of using the same
Umnyakova et al. Peptides and antibiotic resistance
KR20180022007A (ko) 바퀴벌레에서 유래한 항균 펩타이드 페리플라네타신-4 및 그의 조성물

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20220614